Drugs / Piperacillin/Tazobactam
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00816790 | Jan 2009 → May 2011 | acute kidney injury, infectious disease with sepsis | Fraser Health | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Piperacillin/Tazobactam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00816790 ↗ |
| Route | Intravenous | “Piperacillin/Tazobactam 4.5g IV q 6h x 24 hours” NCT00816790 ↗ |